Healthcare provider profile · identity verified

Erik J Sather, MD

Family Practice · DULUTH, MN · NPI 1518971118

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	267	81
Lisinopril	Lisinopril	261	66
Amlodipine Besylate	Amlodipine Besylate	218	52
Omeprazole	Omeprazole	193	47
Levothyroxine Sodium	Levothyroxine Sodium	157	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	147	24
Hydrochlorothiazide	Hydrochlorothiazide	126	34
Gabapentin	Gabapentin	121	32
Metoprolol Succinate	Metoprolol Succinate	119	32
Losartan Potassium	Losartan Potassium	116	35
Tamsulosin Hcl	Tamsulosin Hcl	116	31
Metformin Hcl	Metformin Hcl	103	25
Metformin Hcl Er	Metformin Hcl	95	27
Simvastatin	Simvastatin	90	20
Prednisone	Prednisone	80	29
Albuterol Sulfate Hfa	Albuterol Sulfate	78	28
Sertraline Hcl	Sertraline Hcl	76	22
Furosemide	Furosemide	72	21
Rosuvastatin Calcium	Rosuvastatin Calcium	72	18
Pantoprazole Sodium	Pantoprazole Sodium	71	18
Metoprolol Tartrate	Metoprolol Tartrate	70	21
Allopurinol	Allopurinol	64	16
Trazodone Hcl	Trazodone Hcl	63	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	13
Montelukast Sodium	Montelukast Sodium	55	12
Fluticasone Propionate	Fluticasone Propionate	53	14
Eliquis	Apixaban	50	13
Warfarin Sodium	Warfarin Sodium	50	15
Zolpidem Tartrate	Zolpidem Tartrate	50	suppressed
Xarelto	Rivaroxaban	48	11
Pregabalin	Pregabalin	46	suppressed
Bupropion Xl	Bupropion Hcl	44	suppressed
Famotidine	Famotidine	42	14
Oxybutynin Chloride	Oxybutynin Chloride	42	suppressed
Jardiance	Empagliflozin	40	suppressed
Finasteride	Finasteride	39	suppressed
Memantine Hcl	Memantine Hcl	39	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	11
Ondansetron Hcl	Ondansetron Hcl	37	suppressed
Donepezil Hcl	Donepezil Hcl	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	35	suppressed
Clonazepam	Clonazepam	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	33	suppressed
Morphine Sulfate Er	Morphine Sulfate	33	suppressed
Nystatin	Nystatin	31	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	11
Ozempic	Semaglutide	29	suppressed
Enalapril Maleate	Enalapril Maleate	28	suppressed
Ibuprofen	Ibuprofen	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Potassium Chloride	Potassium Chloride	27	12
Atenolol	Atenolol	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Baclofen	Baclofen	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	13
Glycopyrrolate	Glycopyrrolate	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Arnuity Ellipta	Fluticasone Furoate	20	suppressed
Carvedilol	Carvedilol	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	16	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Glipizide	Glipizide	15	suppressed
Nitroglycerin	Nitroglycerin	15	14
Buprenorphine Hcl	Buprenorphine Hcl	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Temazepam	Temazepam	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Valproic Acid	Valproic Acid	13	suppressed
Xtampza Er	Oxycodone Myristate	13	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error